Literature DB >> 26062524

Delayed-onset heparin-induced thrombocytopenia without thrombosis in a patient receiving postoperative thromboprophylaxis with rivaroxaban.

Brigitte Tardy-Poncet, Michèle Piot, Aurélie Montmartin, Aimé Burdier, Emilie Chalayer, Bernard Tardy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26062524     DOI： 10.1160/TH14-07-0593

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  6 in total

Review 1.  Novel oral anticoagulants for heparin-induced thrombocytopenia.

Authors:  Jessica W Skelley; Jeffrey A Kyle; Rachel A Roberts
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

Review 2.  Emerging Role of Direct Oral Anticoagulants in the Management of Heparin-Induced Thrombocytopenia.

Authors:  Phu Ngoc Tran; Minh-Ha Tran
Journal:  Clin Appl Thromb Hemost       Date:  2017-03-06       Impact factor: 2.389

3.  Delivery of rivaroxaban and chitosan rapamycin microparticle with dual antithrombosis and antiproliferation functions inhibits venous neointimal hyperplasia.

Authors:  Peng Sun; Haoliang Wu; Hao He; Liwei Zhang; Yuanfeng Liu; Cong Zhang; Chunyang Lou; Jingan Li; Hualong Bai
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

4.  Autoimmune Heparin-Induced Thrombocytopenia: Treatment Obstacles and Challenging Length of Stay.

Authors:  Preethi Ramachandran; Fady Farag; Rewais Morcus; Vladimir Gotlieb
Journal:  Am J Case Rep       Date:  2019-03-09

Review 5.  Dabigatran approaching the realm of heparin-induced thrombocytopenia.

Authors:  Patricia J Ho; Juan A Siordia
Journal:  Blood Res       Date:  2016-06-23

6.  Rivaroxaban Treatment for Heparin-Induced Thrombocytopenia: A Case Report and a Review of the Current Experience.

Authors:  Mohamed Aon; Omar Al-Shammari
Journal:  Case Rep Hematol       Date:  2020-09-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.